Skip to main content

Table 2 Characteristics of portal vein thrombosis

From: Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients

Site of portal vein thrombosis

n = 52

 

 MPV

11

21%

 MPV + intrahepatic branch

17

32%

 MPV + SMV

6

11%

 MPV + SMV + intrahepatic branch

3

6%

 MPV + SV

2

4%

 MPV + SV + intrahepatic branch

2

4%

 MPV + SMV + SV

2

4%

 MPV + SMV + SV + intrahepatic branch

1

2%

 SMV

2

4%

 SMV + intrahepatic branch

1

2%

 RPV

2

4%

 LPV

2

4%

 LPV + SV

1

2%

Degree of portal vein thrombosis

n = 52

 

 Partial obstruction

46

89%

 Complete obstruction

6

11%

Bauer’s Classification

n = 52

 

 Grade I

0

0%

 Grade II

15

29%

 Grade III

26

50%

 Grade IV

11

21%

Period from diagnosis to treatment

n = 52

 

  ≤ 30 days

32

62%

  > 31 days

20

38%

Period from last test not showing thrombosis to treatment

n = 52

 

  ≤ 90 days

14

27%

 91–180

12

23%

  > 181 days

14

27%

 Undetermined

12

23%

  1. MPV Main portal vein, SMV Superior mesenteric vein, SV splenic vein, RPV Right portal vein, LPV Left portal vein